Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

BACKGROUND Factors predictive of renal outcome were investigated in 219 cases of biopsy-proven Henoch-Schönlein purpura nephritis (HSPN); 83 children and 136 adults enrolled in a national study were followed up for up to 27 years (median, 4.5 years). METHODS The criterion for defining disease progression was time elapsed until doubling of baseline creatinine level and until dialysis therapy. Age, sex, data at onset (renal function, proteinuria, hematuria, hypertension, and crescents), and data during follow-up (proteinuria and therapy) were tested as covariates. RESULTS Multivariate Cox regression analysis indicated the following parameters as independent prognostic predictors: age (adults versus children, relative risk, 3.57; 95% confidence interval, 1.18 to 10.79; P = 0.024 for creatinine level doubling; relative risk, 14.89; 95% confidence interval, 1.72 to 129.07; P = 0.014 for dialysis therapy), sex (females versus males, relative risk, 5.71; 95% confidence interval, 1.67 to 19.55; P = 0.006 for creatinine level doubling; relative risk, 26.03; 95% confidence interval, 2.64 to 256.73; P = 0.005 for dialysis therapy), and mean proteinuria during follow-up (for each 1 g/d of protein increase, relative risk, 1.77; 95% confidence interval, 1.35 to 2.32; P < 0.001 for creatinine level doubling; relative risk, 1.73; 95% confidence interval, 1.18 to 2.52; P = 0.005 for dialysis therapy). Information for mean proteinuria levels during follow-up increased the sensitivity at logistic regression to 62.5%, with dialysis therapy as the end point. No data detected at diagnosis, including renal function impairment, proteinuria, hypertension, and crescentic nephritis (involving > 50% of glomeruli in only 2.6%), were significantly related to functional decline at multivariate Cox. CONCLUSION This analysis indicates that, even more than when decreased renal function, severe proteinuria, hypertension, or crescents are present at onset, the risk for progression of HSPN (greater in adults and females) was associated with increasing mean proteinuria levels during follow-up.

[1]  P. S. Kellerman Henoch-Schönlein purpura in adults. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  G. D'Amico,et al.  Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. , 2004, Seminars in nephrology.

[3]  Y. Kawasaki,et al.  Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  M. Nuutinen,et al.  The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study , 2002, The Lancet.

[5]  V. Rauta,et al.  Henoch-Schoenlein nephritis in adults-clinical features and outcomes in Finnish patients. , 2002, Clinical nephrology.

[6]  E. Thervet,et al.  Henoch-Schönlein Purpura in adults: outcome and prognostic factors. , 2002, Journal of the American Society of Nephrology : JASN.

[7]  D. Cattran,et al.  Predicting progression in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  R. Wyatt,et al.  Evidence-based assessment of treatment options for children with IgA nephropathies , 2001, Pediatric Nephrology.

[9]  G. Bakris,et al.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  C. Bernard,et al.  Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. , 2000, The Journal of pediatrics.

[11]  K. Schärer,et al.  Clinical outcome of Schönlein-Henoch purpura nephritis in children , 1999, Pediatric Nephrology.

[12]  M. Hattori,et al.  Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  P. Rieu,et al.  Henoch-Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations. , 1999, Annales de medecine interne.

[14]  R. Coppo,et al.  Clinical features of Henoch-Schönlein purpura. Italian Group of Renal Immunopathology. , 1999, Annales de medecine interne.

[15]  S. Honda,et al.  Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. , 1998, Kidney international.

[16]  P. Niaudet,et al.  Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis , 1998, Pediatric Nephrology.

[17]  A. Lupo,et al.  Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[19]  R. White,et al.  Long-term follow-up of childhood Henoch-Schönlein nephritis , 1992, The Lancet.

[20]  J. Savage,et al.  Long term renal prognosis of Henoch-Schönlein Purpura in an unselected childhood population , 1988, European Journal of Pediatrics.

[21]  P. Niaudet,et al.  Clinicopathologic correlations in severe forms of Henoch-Schönlein purpura nephritis based on repeat biopsies. , 1984, Contributions to nephrology.

[22]  A. Cameron,et al.  Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis. , 1981, Clinical nephrology.

[23]  Claudio Pozzi,et al.  Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. , 2004, Journal of the American Society of Nephrology : JASN.

[24]  J. Feehally IgA nephropathy and Henoch-Schönlein purpura , 1999 .

[25]  Gb. Haycock The nephritis of Henoch-schonlein purpura , 1998 .

[26]  R. Hogg Prognostic indicators and treatment of childhood IgA nephropathy. , 1995, Contributions to nephrology.

[27]  M. Lévy,et al.  Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. , 1976, Advances in nephrology from the Necker Hospital.